Aetna, Cigna and Elevance Health, it seems, don't want the members their rivals left behind for the same reasons those other ...

Analyst Steve Baxter of Wells Fargo maintained a Hold rating on Cigna (CI – Research Report), retaining the price target of $355.00.

Shares of Cigna Group (NYSE: CI), the healthcare company, were rising today after the company announced in a press release ...

Cigna Group reaffirms 2024 EPS outlook, reports strong Q3 results, and clarifies it is not pursuing a merger with Humana amid ...

Additionally, in light of recent and persistent speculation, The Cigna Group expects to communicate that the company is not ...

Cigna said it isn't seeking to buy Humana, bolstering its stock and weighing on the share price of the Medicare-focused company. Cigna spoke out because of ongoing speculation it would strike a deal ...

Cigna said it will not pursue a merger with rival Humana after reports last month of renewed talks about a potential deal. Talks of a deal ...

Late last year, The Wall Street Journal reported that Cigna was in talks with Humana for a healthcare merger but abandoned its pursuit after shareholders balked at a deal that would have created a ...

The two health insurance giants, with a combined market value of roughly $125 billion, held talks about a deal last year.

In light of recent and persistent speculation, The Cigna Group (CI) expects to communicate that the company is not pursuing a combination with ...

1 Day CI 7.28% DJIA 0.69% S&P 500 0.10% Financial Services 0.53% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the ...

Cigna projected 2025 profit growth of at least 10% on Thursday, after posting quarterly results that beat Wall Street expectations, driven by strong demand for its specialty drugs and new clients for ...